Barclays upgraded Agilent (A) to Equal Weight from Underweight with a price target of $145, up from $135. The firm says the company’s “upgrade cycle” is in “full swing” and its “conservative” guide setts up potential for a beat-and-raise year in 2025. Barclays says it held onto its Underweight thesis for too long as it was waiting to see more visible signs of the recovery, resulting in the shares outperforming the group over the past six months. The firm sees little risk to the upgrade cycle getting derailed in the near-term.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on A:
- Agilent price target raised to $156 from $150 at BofA
- Agilent price target raised to $145 from $135 at Bernstein
- Agilent Technologies Navigates AI Integration Challenges Amid Regulatory and Ethical Concerns
- Agilent investor day calls for margin expansion, says Goldman Sachs
- Agilent to hold analyst and investor day